HALO logo
halo search icon
Vivos Therapeutics, Inc.

US$0.58

Price Change Indicator
-0.0052 (-0.881%)
Vivos Therapeutics, Inc.
VVOS · NAS

Vivos Therapeutics, Inc.

Start Trading VVOS for Free

US$0.58

Price Arrow-0.0052 (-0.881%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Vivos Therapeutics, Inc. Overview

VVOS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About VVOS

icon
icon

Telephone

1.844.672.4357

icon

Address

Suite 210, 7921 Southpark Plaza, Littleton, CO 80120

Description

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.

VVOS Price Chart

Key Stats

Market Cap

US$8.03M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.57 - 7.95

Trade Value (12mth)

US$286,198.00

1 week

-7.96%

1 month

-42.72%

YTD

-76.68%

1 year

-71.77%

All time high

360.25

Key Fundamentals

EPS 3 yr Growth

-92.00%

EBITDA Margin

-106.50%

Operating Cashflow

-$15m

Free Cash Flow Return

-256.10%

ROIC

-355.20%

Interest Coverage

0.00

Quick Ratio

0.20

Other Data

Shares Outstanding (Fully Diluted)

9m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

VVOS Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
21 May 26
23 April 26
16 April 26

VVOS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-11.14-2.22-2.06locklocklock
EPS (Fully Diluted)
 $locklocklocklock-11.14-2.22-2.06locklocklock
Growth
 %locklocklocklock5780.17.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Vivos Therapeutics, Inc. (VVOS:NAS)?
Halo FAQ
The current share price of Vivos Therapeutics, Inc. (VVOS:NAS) is USD$0.58.
What is the 52-week high share price for Vivos Therapeutics, Inc. (VVOS:NAS)?
Halo FAQ
The 52-week high share price for Vivos Therapeutics, Inc. (VVOS:NAS) is USD$7.95.
What is the 52-week low share price for Vivos Therapeutics, Inc. (VVOS:NAS)?
Halo FAQ
The 52-week low share price for Vivos Therapeutics, Inc. (VVOS:NAS) is USD$0.57.
What is the dividend yield for Vivos Therapeutics, Inc. (VVOS:NAS)?
Halo FAQ
Vivos Therapeutics, Inc. (VVOS:NAS) does not pay a dividend.
What was Vivos Therapeutics, Inc. (VVOS:NAS) last dividend payment?
Halo FAQ
Vivos Therapeutics, Inc. (VVOS:NAS) does not pay a dividend.
What is the franking level for Vivos Therapeutics, Inc. (VVOS:NAS)?
Halo FAQ
Vivos Therapeutics, Inc. (VVOS:NAS) has a franking level of 0.00%.
In which sector is Vivos Therapeutics, Inc. (VVOS:NAS) classified?
Halo FAQ
Vivos Therapeutics, Inc. (VVOS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial